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Psoriatic arthritis (PsA) is a seronegative, inflammatory joint disease associated with psoriasis. In most patients
with PsA, skin lesions precede arthritis; however, the causality of skin inflammation for the development of
arthritis remains unclear. Gp130F759/F759 knock-in (F759) mice develop autoimmune arthritis after 1 year of age
through persistent signal transducer and activator of transcription 3 (Stat3) activation due to impairment in
SOCS3-dependent negative regulation. Here, we crossed F759 mice with K5.Stat3C transgenic mice, in which
keratinocytes express constitutive active Stat3 (Stat3C), leading to generation of psoriasis-like skin change. F759
mice harboring the K5.Stat3C transgene not only had aggravated skin lesions but also spontaneously developed
arthritis with high penetrance in adjacent paws as early as 3 weeks of age. The joint lesions included swelling of
the peripheral paws and nail deformities contiguous with the skin lesions, closely resembling PsA. Histopatho-
logic study revealed enthesitis and bone erosions, with mononuclear cell infiltrates. Quantitative reverse
transcriptase–PCR (RT–PCR), immunohistochemical analyses, and flow cytometry showed upregulation of the
IL-23/T helper type 17 (Th17) pathway in affected joints. Furthermore, enforced generation of psoriasis-like skin
inflammation by topical treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA) in F759 mice induced
swelling of the underlying joints. This animal model renders psoriatic inflammation as the driver of arthritis
and helps to further understand the pathogenesis of PsA.
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INTRODUCTION
Psoriatic arthritis (PsA) is an inflammatory seronegative spon-
dyloarthropathy associated with psoriasis. The prevalence
of PsA among patients with psoriasis is 20–30% (Gladman
et al., 2005; Radtke et al., 2009). The majority of PsA patients
present with psoriasis vulgaris (PsV) before the development
of arthritis. Clinical features of PsA include peripheral
arthritis, axial arthritis (spondylitis), enthesitis, dactylitis, and
tenosynovitis (Gottlieb et al., 2008). Distal interphalangeal
joints are frequently affected in PsA patients. Furthermore, nail
involvement occurs in a majority of PsA patients. Recent
studies demonstrated that the extended nature of the enthesis
associated with distal interphalangeal joints leads to the
diffuse nature of the inflammatory responses around the nail
in PsA, as nails are functionally linked to the distal phalanx
and enthesis (Tan et al., 2007; McGonagle et al., 2009).
This notion explains why nail disease is frequently found in
PsA patients, in particular, those with distal interphalangeal
arthritis (Gottlieb et al., 2008). Although PsV precedes
arthritis in most patients with PsA, it remains unknown as to
whether the skin and joint diseases are pathophysiologically
related.
Psoriasis is a common chronic inflammatory skin disease
characterized by increased proliferation, altered differentiation
of the epidermis, and inflammatory cell infiltrates in the
dermis. Recent studies have demonstrated that IL-23, which
is essential for the development of T helper type 17 (Th17)
cells, is functionally involved in the pathogenesis of psoriasis
(Fitch et al., 2007). The therapeutic efficacy of antibodies to
IL-23, including those against either the p40 or p19 subunits,
has confirmed the role of IL-23 in psoriasis (Krueger et al.,
2007; Nograles and Krueger, 2011). Similarly, tumor necrosis
factor (TNF) inhibitors attenuate psoriasis through inhibition of
the IL-23/Th17 pathway (Zaba et al., 2007). More recently,
direct targeting of the IL-17 pathway using monoclonal
antibodies to IL-17A or the IL-17 receptor has proven to be
a more potent approach to treat psoriasis (Spuls and Hooft,
2012). As most biologics for psoriatic skin disease also
attenuate arthritis in PsA patients, it has been suggested that
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an immunological pathomechanism is shared by those joint
and skin diseases (Raychaudhuri et al., 2012).
Recent genetic analyses demonstrated that PsV and PsA
harbor common susceptibility genes, including those asso-
ciated with HLA class I, NF-kB and IFN signaling, and the IL-
23/Th17 pathway (Nograles et al., 2009; Elder et al., 2010;
Rahman and Elder, 2012). Some genes are more strongly
associated with PsA than with PsV (Lloyd et al., 2012).
However, the underlying mechanism for the ‘‘PsV to PsA
transition’’ still remains unclear. Traumatic injury in joints has
been recognized to be a trigger for the subsequent
development of PsA, known as joint Koebner or the
deep Koebnerization (Punzi et al., 1998; McGonagle et al.,
2011).
The elucidation of the pathogenesis of PsA has been
hampered by the relative paucity of biopsy specimens from
joint lesions. Furthermore, relevant animal models of PsA are
not available, although the generation of arthritis has been
described in some murine models of psoriasis (Zenz et al.,
2005; Hwang et al., 2011). We have recently established a
mouse model of psoriasis, K5.Stat3C transgenic mice, in
which a constitutively active signal transducer and activator
of transcription 3 (Stat3) transgene (Stat3C) is expressed in the
epidermis. These mice develop psoriasis-like lesions either
spontaneously or induced by wounding stimuli or topical
treatment with 12-O-tetradecanoyl phorbol-13-acetate (TPA)
(Sano et al., 2005, 2008). Their skin lesions resemble psoriasis
regarding the clinical appearance, histopathology,
immunological conditions including the activation of IL-23/
Th17 signaling, and sensitivities to biological agents such as
monoclonal antibodies to IL-17A, IL-12/23p40, and IL-23p19
(Nakajima et al., 2011). However, K5.Stat3C mice do not
develop arthritis even if the skin lesions become severe.
Gp130F759 homozygous knock-in (referred to as F759) mice
harbor a mutant variant of gp130 where Y759 is substituted for
phenylalanine (F), leading to Stat3 activation due to the
absence of SOCS3-mediated suppression (Ohtani et al.,
2000). The IL-6/gp130/Stat3 pathway in F759 mice induces
Th17 cell activation with age, leading to the development of
rheumatoid arthritis–like disease in the limbs at 12–18 months
after birth (Atsumi et al., 2002). In this study, we crossed F759
mice with K5.Stat3C mice and found that K5.Stat3C:F759
mice spontaneously develop severe psoriasis-like lesions and
joint diseases in their paws as early as 3 weeks of age. In
addition, the potential involvement of the IL-23/Th17 pathway
in the development of arthritis suggests that K5.Stat3C:F759
mice represent a relevant model of PsA. Similar to the effect of
introduction of Stat3C transgene, enforced development of
psoriasis-like lesions in F759 mice by topical application of
TPA led to swelling of the underlying joints, suggesting that
psoriatic inflammation facilitated arthritis.
RESULTS
K5.Stat3C:F759 mice spontaneously develop severe psoriatic
skin lesions and swelling of the paws
We crossed K5.Stat3C mice with F795 mice, and the pheno-
types were compared among the pups harboring genotypes
of F759/0 (heterozygous), F759 (homozygous), K5.Stat3C:
F759/0, and K5.Stat3C:F759. Strikingly, K5.Stat3C:F759 mice
showed swelling in the paws from 3 weeks of age, and most of
them became worse as they aged (Figure 1a). Mice with the
other three genotypes did not develop any joint disease during
the study. In addition, K5.Stat3C:F759 mice simultaneously
developed scaly skin lesions in the paws, whereas the skin of
K5.Stat3C:F759/0 remained intact. This observation suggested
that Stat3 activation in epidermal keratinocytes of K5.Stat3C
mice was reinforced by SOCS3 inhibition due to the
F759 mutation in the gp130 gene (Ohtani et al., 2000). The
18F-fluorodeoxyglucose positron emission tomography (FDG-
PET) imaging, by which inflamed joints of PsA are detected
(Tan et al., 2006; Takata et al., 2011), revealed a distinct
accumulation of 18F-FDG in the hindlimb paws of
K5.Stat3C:F759 mice (Figure 1e), suggesting inflammation in
the joints, whereas the paws of F759 mice showed accumula-
tion at the background level (Figure 1d). Histopathology of the
paws revealed that K5.Stat3C:F759 mice showed psoriasis-like
changes, including acanthosis and dermal cell infiltrates
(Figure 1g), whereas mice with the other three genotypes
were devoid of dermal inflammation (Figure 1f). The joint
involvements in the paws were evaluated according to the
clinical severity from 0 to 4, as described in the Materials and
Methods. The cumulative incidence of joint disease during the
first 9 weeks after birth in mice with different geno-
types clearly showed that K5.Stat3C:F759 mice exclusively
developed paw joint involvements (Table 1). The penetrance
of joint disease found in K5.Stat3C:F759 mice was as high as
75% (27 out of 36 mice).
Nail lesions of K5.Stat3C:F759 mice
Mice affected with the most severe disease (clinical score 4)
showed the contracture of paw joints and nail involvement in
addition to scaly, keratotic skin lesions (Figure 2b) compared
with wild-type mice (Figure 2a). The nail lesions in
K5.Stat3C:F759 mice were thickened and hyperkeratotic.
They closely resembled the nail deformities in psoriatic
patients––that is, pitting of nails, oncholysis, and subungual
hyperkeratosis (Tan et al., 2012). Histopathology of the nail
lesions in K5.Stat3C:F759 mice demonstrated a marked
hyperkeratosis in the nail plate, nail matrix, and nail bed
leading to nail deformity and oncholysis (Figure 2d), sharply
contrasting with wild-type mice, in which the nail bed was
attached tightly to the nail plate (Figure 2c). The nail plate
deformity in K5.Stat3C:F759 mice might be due to a hyper-
keratotic abnormality in the nail matrix with underlying
inflammatory cell infiltrates, suggesting carpal enthesitis.
Intracorneal infiltration of neutrophils was also found. Taken
collectively, the nail lesions in K5.Stat3C:F759 mice closely
resemble nail psoriasis clinically and histopathologically in
human PsA.
Severe skin and joint lesions in older K5.Stat3C:F759 mice
As K5.Stat3C:F759 mice aged, the skin lesions and arthritis
tended to become worse. A representative mouse at 31 weeks
of age is shown. They developed progressive skin lesions on
the limbs, tails, and back, in which a very thickly scaled
‘‘ostraceous psoriasis-like’’ feature was noted (Figure 3a, b,
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and d). Both front and hind paws were bent, and some of them
showed a ‘‘drumstick-like appearance’’ (Figure 3c). Nail
hyperkeratosis was also observed. Histopathologically, epi-
dermal hyperplasia and dense mononuclear cell infiltrates
in the dermis and around periarticular regions were observed
(Figure 3e). At higher magnification, bone erosions with
mononuclear cell infiltrates in the first phalanx were
observed (Figure 3e, bottom). Therefore, it is likely that the
aggravation of skin lesions and the joint involvements are
associated.
Cytokine profiles and Th17 cell infiltrates in affected joints of
K5.Stat3C:F759 mice
Previous studies demonstrated that rheumatoid arthritis and
PsA are associated with the IL-23/Th17 pathway (Jandus et al.,
2008). Quantitative reverse transcriptase–PCR (RT–PCR)
analysis of dissected periarticular tissues from the affected
joints of K5.Stat3C:F759 mice, compared with F759 mice,
revealed the upregulation of genes encoding proinflam-
matory cytokines, including TNFa, IL-1b, and IL-6, and
Th17-associated cytokines, including IL-12/23p40, IL-23p19,
and IL-17A (Figure 4a; green bars vs. blue bars). The similar
trend in cytokine profiles was observed in unaffected
K5.Stat3C:F759 mice, but some of them (e.g., IL-6, IL-10)
were preferentially increased in animals with arthritis.
(Figure 4a; green bars vs. red bars). Immunohistochemical
staining of the affected joints confirmed that the infiltrating
cells or residential cells such as fibroblasts produced TNFa, IL-
6, IL-17A, and CCL20 in the dermis and in periarticular
regions (Figure 4b). CCL20 attracts Th17 cells in psoriatic
lesions through engagement of the specific receptor, CCR6
(Harper et al., 2009; Hedrick et al., 2009). In contrast, there
were no TNFa-, IL-17A-, or CCL20-expressing cells in the
tissues of F759 mice, although there were some IL-6-
expressing cells in periarticular regions (Supplementary
Figure S1 online). As much fewer IL-6-positive cells were
found in the tissues of F759/0 mice, homozygous F759
Table 1. The cumulative incidence of joint disease in
mice of the indicated genotypes during the first 9
weeks after birth
Score
F759/0
(n¼42)
F759
(n¼ 55)
K5.Stat3C:F759/0
(n¼59)
K5.Stat3C:F759
(n¼ 36)
0 42 55 59 9
1 0 0 0 12
2 0 0 0 12
3 0 0 0 1
4 0 0 0 2
3
5
7
9
* *
(Wk)
F759/0 F759F759
K5.Stat3C:
Figure 1. Early development of skin lesions and arthritis in the paws of K5.Stat3C:F759 mice. (a) Progression of skin lesions and swelling of paw digits are
shown from 3 to 9 weeks of age in K5.Stat3C:F759 mice, whereas F759 and K5.Stat3C:F759/0 mice remain unaffected. Representative views of paw digits and
respective 18F-fluorodeoxyglucose positron emission tomography (18F-FDP PET) imaging of an F759 mouse (b, d) and a K5.Stat3C:F759 mouse (c, e). Histology of
paws in the hindlimbs of (f) F759 and (g) K5.Stat3C:F759 mice. Square areas are shown at high magnification in insets. Note the hyperplastic epidermis and dermal
infiltrates (arrow) in K5.Stat3C:F759 mice (g, inset) compared with F759 mice (f, inset). Asterisks indicate epidermis. Hematoxylin and eosin (H&E) staining.
Bars¼ 200mm.
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mutation conferred the IL-6 amplifier loop in the joints
(Murakami and Hirano, 2012). Flow cytometric analysis
using cells from the digested periarticular tissues in K5.Stat3C:
F759 mice revealed that CD4þ cells were predominant
T cells. Among CD4þ cells, the percentages of CCR6þ cells
were increased (B20% of CD4þ cells) in joint tissues
compared with those in lymph nodes (B5% of CD4þ cells;
Figure 4d). These data strongly suggested that Th17 cells
preferentially accumulated or proliferated in the diseased
joints, as Th17 cells specifically express CCR6 (Harper et al.,
2009; Hedrick et al., 2009).
Stat3 activation in both the epidermis and periarticular
fibroblasts in K5.Stat3C:F759 mice
The epidermis of K5.Stat3C:F759 mice showed intense Stat3
activation due to keratinocyte-specific Stat3C expression
together with gp130-mediated Stat3 activation (Figure 4c). In
addition, the cells around joints were also positive for Stat3
staining in their nuclei (Figure 4c, inset), indicating Stat3
activation. Double immunohistochemical staining revealed
that periarticular fibroblasts in the affected joints exhibited
Stat3 activation (Figure 4c, bottom panel). This finding under-
scored Stat3 activation in joint fibroblasts that contributes to
NP
NP
NB
NB
*
FP
FP
NM
NM
Figure 2. Nail lesions of K5.Stat3:F759 mice. (a, b) Representative features of nail symptoms of K5.Stat3C:F759 mice at 6 weeks of age (b) compared with control
mice (a). (c, d, left panels) Histology of nails in K5.Stat3:F759 mice (d) and control mice (c). Bars¼ 200mm. (c, d, right panels) Higher magnifications of the
rectangular areas. Bars¼ 80mm. FP, first phalanx; NB, nail bed; NM, nail matrix; NP, nail plate. Arrowhead indicates intracorneal pustules with neutrophils, arrows
indicate cell infiltrates in carpal enthuses (enthesitis), and asterisk indicates dermal cell infiltrates and capillary proliferation. Hematoxylin and eosin (H&E) staining.
Figure 3. Progressive skin and joint disease in K5.Stat3:F759 mice as they age. (a–d) Representative features of an aged mouse at 31 weeks are shown.
(a) Scaly lesions on the body. (b) Lower dorsal skin shows very thick scaly lesions, resembling an oyster shell (so-called ostraceous psoriasis-like). Changes of
paws in the (c) forelimbs and (d) hindlimbs. Arrows indicate joint bending and contracture and arrowhead indicates drumstick-like appearance. (e) Histology of the
paw in the hindlimb of aged K5.Stat3C:F759 mice (31 weeks). Bottom panel indicates higher magnification of the rectangular area in the top panel. Arrows
indicate bone erosions with mononuclear cell infiltrates. Hematoxylin and eosin (H&E) staining. Bars¼200mm and 50mm in the top and bottom panels,
respectively.
M Yamamoto et al.
Psoriatic Skin Lesions Facilitate Arthritis
448 Journal of Investigative Dermatology (2015), Volume 135
the early development of arthritis in F759 mice (Murakami
et al., 2011). Previous study demonstrated that overproduction
of IL-7 by fibroblasts was mediated by gp130/Stat3 signaling
and was relevant to pathogenesis in F759 mice (Sawa et al.,
2006). We found that IL-7 mRNA was upregulated in the
periarticular tissues from K5.Stat3C:F759 mice compared with
asymptomatic F759 mice, suggesting contribution of IL-7 to
arthritis (Supplementary Figure S2 online).
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Figure 4. Periarticular cytokine profiles, infiltrating cells, and serum cytokines in diseased K5.Stat3C:F759 mice. (a) Relative mRNA levels of cytokines in
periarticular tissues from K5.Stat3C:F759 mice with arthritis (green bars, n¼4, 4–14 weeks old), unaffected K5.Stat3C:F759 mice (red bars, n¼ 4, 4–18 weeks old),
and F759 mice (blue bars, n¼4, 4–14 weeks old). Data are reported as means±SD; *Po0.05 by Mann–Whitney U-test. (b) Immunohistochemical staining of
paws in the hindlimbs of a representative K5.Stat3:F759 mouse at 31 weeks of age with monoclonal antibodies against the indicated molecules. Higher
magnification images are shown in the squares. Bars in images with low magnification¼ 50mm (tumor necrosis factor (TNF), IL-6, and IL-17A) and 100mm
(CCL20). Bars in squares¼ 20mm (TNF, IL-6, and IL-17A) and 40mm (CCL20). (c) Signal transducer and activator of transcription 3 (Stat3) activation in the
epidermis and subdermal fibroblasts in K5.Stat3C:F759 mice. Periarticular area with higher magnification is shown in the square (inset of top panel). Double
immunohistochemistry of dermis and enthesis using anti-Stat3 (blue) and anti-fibroblasts (brown) (bottom panel). Arrows indicate entheseal fibroblasts with nuclear
Stat3. Bars in top panel¼100mm and 40mm (inset). Bar in bottom panel¼ 20mm. EP, epidermis; FP, first phalanx. (d) Flow cytometric analysis using lymph node
cells (LNCs) and periarticular infiltrating cells (PACs) in K5.Stat3C:F759 mice at 6 weeks of age with joint disease. Numbers in quadrants indicate percentages.
A representative result from three experiments is shown. (e) Serum levels of IL-6 and IL-17A in mice with genotypes of F759/0 (n¼ 4, 6; 4–14 weeks old),
K5.Stat3C:F759/0 (n¼ 4, 5; 4–21 weeks old), F759 (n¼ 5; 4–14 weeks old), and diseased K5.Stat3C:F759 (n¼ 5, 6; 4–21 weeks old). Data are reported as
means±SD; *Po0.05 and **Po0.01 versus values from K5.Stat3C:F759 mice by Mann–Whitney U-test.
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Circulating cytokines in K5.Stat3C:F759 mice
Serum levels of IL-6 and IL-17A in K5.Stat3:F759 mice with
arthritis were significantly higher than those in mice of other
genotypes, including F759/0, F759, or K5.Stat3C:F759/0
(Figure 4e). These data suggested the direct contribution of
arthritis to the elevation of these cytokines, or an abnormality
of the systemic immunity in K5.Stat3C:F759, in which IL-6
amplifier loop (Murakami and Hirano, 2012) and IL-23/Th17
activation were involved.
Enforced development of psoriasis-like skin lesion by topical
treatment with TPA induces joint disease in F759 mice
Similar to K5.Stat3C mice (Sano et al., 2005), F759 mice
developed psoriasis-like lesions by topical TPA treatment
(Supplementary Figure S3 online), as they harbored persistent
Stat3 activation due to impairment in SOCS3 (Ohtani et al.,
2000). TPA-treated ear skins demonstrated psoriasis-like
histopathologic features including epidermal hyperplasia,
hyperkeratosis, subcorneal pustules with neutrophils, and
dense cell infiltrates in the dermis (Figure 5a). Immunostaining
of the lesions demonstrated a dense infiltrate of IL-17-produ-
cing gdT cells (the so-called gd-17 cells) predominantly in
the upper dermis and Th17 cells in the deeper dermis
(Supplementary Figure S4 online). Furthermore, RT–PCR using
the skin lesions revealed upregulation of psoriasis-related
genes including the IL-12/23p40, IL-17A, IL-1b, IL-6,
b-defensins 3 and 4, and S100A8/9 (Supplementary Figure
S5 online). Interestingly, TPA application three times weekly
for 3 weeks onto the paws resulted in not only development of
skin lesions but also paw swelling in F759 mice, whereas
nontransgenic control mice did not show either (Figure 5c and
d). Histopathology of topical TPA-treated hind paws demon-
strated dense inflammatory cells in not only the skin but also
the underlying tendon and enthesis, whereas much fewer cells
were found in control mice (Figure 5e). Taken together, skin
lesions induced by either K5.Stat3C transgene or topical TPA
treatment facilitated joint disease in arthritis-prone F759 mice
that otherwise occurred much later in life.
DISCUSSION
PsA is usually preceded by plaque-type psoriasis (PsV)
(Gladman et al., 2005; Radtke et al., 2009); however, it
remains unknown whether these skin and joint diseases are
pathophysiologically related. Here, we demonstrate that the
psoriatic skin inflammation can facilitate the onset of joint
disease in arthritis-prone mice.
F759 mice spontaneously develop rheumatoid arthritis–like
joint disease at 12–18 months after birth (Atsumi et al., 2002).
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Figure 5. The 12-O-tetradecanoylphorbol-13-acetate (TPA)-mediated psoriasis-like inflammation leads to joint swelling in F759 mice. (a, b) Topical TPA
treatment induces psoriasis-like lesions in F759 mice. (a) Histology of ear skins of F759 mice treated with acetone alone (left) and TPA (right) three times weekly for
3 weeks (white arrow, subcorneal pustules; black arrow, inflammatory cell infiltrates; hematoxylin and eosin (H&E) staining, bars¼ 100mm), and (b) epidermal
thickness (mm)±SD after treatment (n¼ 6 each; **Po0.01). (c, d, e) Topical TPA application onto limb skins leads to paw swelling with inflammatory cell
infiltrates. (c) Representative views of forelimbs of C57/BL6 mice (top panels) and F759 mice (bottom panels) treated for 3 weeks with acetone alone (left panels) or
TPA (right panels). Scaly skin lesion (black arrow) and swelling of forelimb paw (white arrows). (d) D Swelling (from baseline, mm±SD) of forelimb paws of
F759 mice at 3 weeks of treatment with acetone (n¼5) and TPA (n¼ 5). **Po0.01. (e) Representative histology of paws in the hindlimbs treated with acetone
alone (top panels) or TPA (bottom panels) in F759 mice. Rectangular areas in left panels are shown at high magnification in right panels. Note that dense cell
infiltrates in the dermis extend to the periarticular area. Arrows indicate inflammatory cell infiltrates in the tendon/enthesis. H&E staining, bars¼200mm.
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Tissues of F759 mice show constitutive activation of IL-6
signaling that leads to persistent Stat3 activation because
of impaired SOCS3-negative feedback (Ohtani et al., 2000;
Sawa et al., 2006; Murakami and Hirano, 2012). Arthritis
in F759 mice occurs through interaction between Th17
cells and nonimmune cells, in particular joint fibro-
blasts, where the IL-6 amplifier loop with IL-17 stimulation
has a critical role (Ogura et al., 2008; Murakami and Hirano,
2012).
We previously demonstrated that Stat3 activation is
observed in psoriatic epidermis. Accordingly, K5.Stat3C trans-
genic mice, in which the epidermis expresses a constitutively
active Stat3, develop psoriasis-like skin lesions (Sano et al.,
2005). The lesions in K5.Stat3C transgenic mice have striking
similarities to human psoriasis in the histopathology and
functional involvement of the IL-23/Th17 pathway
(Nakajima et al., 2011). In this study, joint disease and other
PsA-associated symptoms like dactylitis and nail disease were
observed in K5.Stat3C:F759 mice with a high penetrance (up
to 75%) from an early age. They simultaneously exhibited
more severe skin disease than K5.Stat3C mice, likely due to
exaggerated Stat3 activation in the epidermis from the
F759 mutation in addition to the Stat3C transgene
expression. It was suggested that this early occurrence of
arthritis in K5.Stat3C:F759 mice was due to simultaneous skin
inflammation. This feature seems to be relevant to PsA that is
characterized by extraarticular inflammation including
enthesitis, dactylitis, and nail involvements (McGonagle
et al., 2007). In addition to epidermal keratinocytes,
entheseal fibroblasts simultaneously showed Stat3 activation
in diseased mice. Our hypothesis for the pathomechanism in
K5.Stat3C:F759 mice is that nonimmune cells––that is, both
keratinocytes and periarticular or entheseal fibroblasts––
showed Stat3 activation in association with Th17 cell
accumulation. One possibility was that infiltration of Th17
cells in psoriatic skin lesions in contiguity to joints might
expedite the arthritis at a few weeks of age. This assumption is
supported by evidence that microtrauma in the joints induces
the early onset of arthritis in F759 mice that otherwise
spontaneously develop arthritis from 12 months of age
(Atsumi et al., 2002). Similar to Koebner phenomenon in
psoriasis, it has been recognized that microdamage is a pivotal
factor in joint diseases including PsA (Punzi et al., 1998;
McGonagle et al., 2007, 2011). Only paw joints were affected
in K5.Stat3C:F759 mice, likely because paw joints are
continuously subjected to physical stress upon moving, a
condition similar to ‘‘deep Koebner.’’ Another reason might be
that paw joints are skin proximity compared with other joints.
In this regard, psoriatic skin lesions in the paws might be
relevant to the Koebner-like triggering for arthritis in
K5.Stat3C:F759 mice. Indeed, enforced generation of
psoriasis-like skin inflammation in F759 mice also facilitated
joint disease, although their phenotype was milder than in
K5.Stat3C:F759 mice. As Stat3 activation occurred because of
impairment in SOCS3 in F759 mice, their skin lesions closely
resembled human psoriasis and psoriasis-like lesions in
K5.Stat3C mice (Sano et al., 2005). It remains undefined,
however, whether other types of skin inflammation, such as
contact dermatitis, cause the arthritis to be accelerated. It
would be helpful to understand the role for psoriasis-like
lesions by treating them with topical steroids or UVB
irradiation to verify whether joint disease would be
simultaneously attenuated. Another hypothesis is that
aggravated skin lesions lead to systemic inflammation, as
shown by elevated serum levels of IL-17A and IL-6, and
subsequently facilitate the onset of arthritis.
Recent genome-wide association studies have identified
non-major histocompatibility complex cytokine genes to
have large roles in PsV and PsA, such as those involved in
the IL-23/Th17 pathway, including IL12B, IL23R, IL23A, and
TRAF3IP2 (Nograles et al., 2009; Elder et al., 2010; Rahman
and Elder, 2012). Indeed, it has been well recognized that the
IL-23/Th17 axis has a pathogenic role for PsV and PsA, and
therefore the biologics targeting IL-23/IL-17 signaling are
clinically beneficial for treatment of both conditions
(Boehncke et al., 2014). This study demonstrated that
periarticular infiltrating cells in diseased K5.Stat3C:F759
mice comprised a considerable number of CD4þCCR6þ
cells, suggesting Th17 cells, as found in psoriasis-like
lesions in K5.Stat3C mice (Nakajima et al., 2011).
Furthermore, the cytokine profiles of the affected joints
strongly suggested the involvement of the IL-1b/IL-6/IL-23/IL-
17 pathway, along with upregulation of TNF, IFN-g, and I
L-10, that recapitulated human PsA (Ritchlin et al., 1998;
Jandus et al., 2008; Leipe et al., 2010). These data imply that
Th1 and regulatory T cells may be also involved, or plasticity
between Th17, Th1, and regulatory T cells may exist as
previously claimed in human arthritis (Lubberts, 2010).
Thus, the immunological milieu in this model mouse
resembles that in PsA; therefore, it is likely that antibodies to
TNF, IL-23, or IL-17A would be effective on joint disease in
K5.Stat3C:F759 mice, as demonstrated by the effects on
K5.Stat3C mice (Nakajima et al., 2011). Treatment with anti-
IL-7 may also affect their joint disease, as previously
found in F759 mice, whose arthritis development was
attributed to IL-7 production by fibroblasts via gp130/Stat3
signaling (Sawa et al., 2006). It should be noted that IL-7 was
found upregulated in psoriatic lesions and PsA joints (Bonifati
et al., 1997; Colucci et al., 2007). Molecular events associated
with Stat3 activation are shared with nonimmune cells such as
keratinocytes and entheseal fibroblasts in this study.
Accordingly, the recent finding of STAT3 as one of the non-
major histocompatibility complex susceptibility genes in
association with PsA, PsV, and AS highlights the role of
Stat3 relevant in pathogenesis (Danoy et al., 2010; Tsoi
et al., 2012; Cenit et al., 2013). It may be possible that
traumatic injury to either the skin or joints in genetically
susceptible individuals contributes to the production of
inflammatory signals that are associated with Stat3
activation, leading to a downstream innate immune response
(Lories and de Vlam, 2012), followed by the activation of
adaptive immunity such as Th17 response. Taken collectively,
our study provides insights into the transition of PsV to PsA
through the cross talk of nonimmune cells and epidermal and
entheseal cells via IL-6 and the IL-23/Th17-associated Stat3
activation.
M Yamamoto et al.
Psoriatic Skin Lesions Facilitate Arthritis
www.jidonline.org 451
MATERIALS AND METHODS
Mice
Details of K5.Stat3C mice (FVB/N) and gp130F759 (C57/BL6) mice have
been previously described (Atsumi et al., 2002; Sano et al., 2005) and
crossed to generate mice with four genotypes: K5.Stat3C/0;gp130F759/
F759, K5.Stat3C/0;gp130F759/0, gp130F759/F759, and gp130F759/0. For
generation of psoriasis-like skin lesions in F759 mice, 10 nmol of TPA
was applied three times weekly for 3 weeks onto right ears or paws of
fore- and hindlimbs, whereas acetone was painted on the left of them as
controls. Paw swelling was evaluated as the increment of swelling of
paws from baseline using a caliper gauge. Experiments were performed
under the institutional approval and strictly adhered to institutional
guidelines for minimizing distress to animals.
Clinical assessment of arthritis
The severity of arthritis in the paws was scored using a scale ranging
from 0 to 4 as follows: score 0, no swelling of digits; score 1, mild
swelling of digits; score 2, severe swelling of digits; score 3,
contracture of digit joints without nail involvement; and score 4,
contracture of digit joints with nail involvement. The highest score in
the paws of each animal was used as the clinical score.
18F-FDG-PET imaging
Mice were fasted for at least 12 hours before 18F-FDG injection.
Anesthesia was induced by inhalation of diethyl ether. 18F-FDG
(27 MBq, Nihon Medi-Physics, Tokyo, Japan) was intravenously
injected into the retro-orbital plexus. Under continuous inhalation
of isoflurane, a 60-minute PET acquisition was started at 30 minutes
after injection using an FX preclinical Platform scanner (X-O X-
PET X-SPECT, Gamma Medica-Ideas, Northridge, CA). PET images
were aligned automatically using image fusion software (PMOD
Technologies, Zurich, Switzerland).
Histopathology and immunohistochemistry
The hindlimbs were fixed in neutral buffered formalin saline and
decalcified in decalcification solution K-CX (Falma, Tokyo, Japan) for
4 days at 4 1C before embedding in paraffin. Antibodies to TNF
(IHCWorld, Woodstock, MD), IL-6 (Santa Cruz Biotechnology, Dallas,
TX), IL-17A (Santa Cruz Biotechnology), CCL20 (AbCam, Cambridge,
UK), and Stat3 (Cell Signaling, Boston, MA) were used. Deparaffinized
and antigen-retrieved sections were treated with primary and second-
ary antibodies conjugated with horseradish peroxidase (Dako,
Glostrup, Denmark) and were visualized with diaminobenzidine and
hematoxylin. The double staining of fibroblasts was performed by two
rounds of immunohistochemical stainings; first with anti-Stat3 anti-
body (Cell Signaling) and Histofine Simple Stain AP (Rabbit) (Nichirei
Biosciences, Tokyo, Japan) followed by treatment with Vector Blue
Alkaline Phosphatase Substrate (Vector, Burlingame, CA). Second,
anti-reticular fibroblasts (ER-TR7, AbCam, Atlanta, GA), Histofine
Simple Stain Mouse MAX PO (Rat) (Nichirei Biosciences), and Vector
NovaRED Peroxidase Substrate (Vector) were used. For immunofluor-
escence staining, 6mm snap-frozen skin sections were treated with a
blocking reagent (Protein Block Serum-Free, Dako) for 1 hour at room
temperature and were treated overnight at 4 1C with primary anti-
bodies including rat anti-mouse CD4 (H129.19. BD Pharmingen, San
Jose, CA), Armenian hamster anti-mouse common gdTCR (GL3, Santa
Cruz Biotechnology), and rabbit anti-mouse IL-17A (H-132, Santa
Cruz Biotechnology), followed by treatment with relevant secondary
antibodies including anti-rat IgG-Alexa 488 (Invitrogen, Carlsbad, CA),
anti-Armenian hamster IgG-FITC (Santa Cruz Biotechnology), and
anti-rabbit IgG-Alexa 594 (Invitrogen).
Quantitative RT–PCR
Periarticular tissues of the digits were dissected and minced with
scissors into small pieces on ice, then disrupted by ultrasonic
sonication. RT–PCR was performed with the primers as previously
described (Nakajima et al., 2011), except for CCL20, IL-10, and IL-7,
for which sense and anti-sense primers were as follows: sense,
50-AACTGGGTGAAAAGGGCTGT-30; anti-sense, 50-GTCCAATTCC
ATCCCAAAAA-30, sense, 50-CAGAGCCACATGCTCCTAGA-30; anti-
sense, 50-TGTCCAGCTGGTCCTTTGTT-30, sense, 50-CGCAGACC
ATGTTCCATGT-30; anti-sense, 50-TCTTTAATGTGGCACTCAGATG
AT-30, respectively. The quantity of each transcript was analyzed
using the 7300 Fast System Software (Applied Biosystems, Tokyo,
Japan) and was normalized to hypoxanthine phophoribosyltransferase
according to the DDCt method.
Flow cytometry
Affected limbs of K5.Stat3C:F759 mice at 6 weeks of age were
dissected, and treated with dispase (BD), followed by treatment with
enzyme mixtures of collagenase (Worthington, Berkshire, UK),
hyaluronidase (Sigma, St Louis, MO), and DNAse (QIAGEN, Tokyo,
Japan) to collect periarticular infiltrating cells. Lymph node cells from
K5.Stat3C:F759 mice were used as controls. Used antibodies were
BV421-anti-CD3 (BD Pharmigen), Alexa Fluor 647-anti-CD4, FITC-
anti-CD8, and PE-Cy7-anti-CCR6 (BioLegend, San Diego, CA).
Experiments were performed on an LSRFortessa X-20 (BD) and
analyzed using FlowJo software (Tree Star, Ashland, OR).
ELISA
Sera from diseased K5.Stat3C:F759 mice and control mice
were analyzed by high-sensitivity ELISA kits for IL-6 and IL-17A
(eBioscience, San Diego, CA) according to the manufacturer’s
protocol.
Statistical analysis
Samples were compared with the Mann–Whitney U-test. P-values of
o0.05 were considered significant.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We thank Drs T Hirano, M Murakami, and K Ishihara for kindly providing
gp130F759 mice and for helpful discussions and Ms R Kamijima for technical
assistance. This work was partly supported by Grants-in-Aid for Scientific
Research from the Ministry of Education, Culture, Sports, Science and
Technology of Japan.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at http://
www.nature.com/jid
REFERENCES
Atsumi T, Ishihara K, Kamimura D et al. (2002) A point mutation of Tyr-759 in
interleukin 6 family cytokine receptor subunit gp130 causes autoimmune
arthritis. J Exp Med 196:979–90
M Yamamoto et al.
Psoriatic Skin Lesions Facilitate Arthritis
452 Journal of Investigative Dermatology (2015), Volume 135
Boehncke WH, Kirby B, Fitzgerald O et al. (2014) New developments in our
understanding of psoriatic arthritis and their impact on the diagnosis and
clinical management of the disease. J Eur Acad Dermatol Venereol
28:264–70
Bonifati C, Trento E, Cordiali-Fei P et al. (1997) Increased interleukin-7
concentrations in lesional skin and in the sera of patients with plaque-
type psoriasis. Clin Immunol Immunopathol 83:41–4
Cenit MC, Ortego-Centeno N, Raya E et al. (2013) Influence of the STAT3
genetic variants in the susceptibility to psoriatic arthritis and Behcet’s
disease. Hum Immunol 74:230–3
Colucci S, Brunetti G, Cantatore FP et al. (2007) Lymphocytes and synovial
fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha,
and IL-7 in an in vitro model derived from human psoriatic arthritis. J
Pathol 212:47–55
Danoy P, Pryce K, Hadler J et al. (2010) Association of variants at 1q32 and
STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn’s
disease. PLoS Genet 6:e1001195
Elder JT, Bruce AT, Gudjonsson JE et al. (2010) Molecular dissection of
psoriasis: integrating genetics and biology. J Invest Dermatol 130:1213–26
Fitch E, Harper E, Skorcheva I et al. (2007) Pathophysiology of psoriasis: recent
advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep 9:461–7
Gladman DD, Antoni C, Mease P et al. (2005) Psoriatic arthritis: epidemiology,
clinical features, course, and outcome. Ann Rheum Dis 64(Suppl 2):
ii14–7
Gottlieb A, Korman NJ, Gordon KB et al. (2008) Guidelines of care for the
management of psoriasis and psoriatic arthritis: Section 2. Psoriatic
arthritis: overview and guidelines of care for treatment with an emphasis
on the biologics. J Am Acad Dermatol 58:851–64
Harper EG, Guo C, Rizzo H et al. (2009) Th17 cytokines stimulate CCL20
expression in keratinocytes in vitro and in vivo: implications for psoriasis
pathogenesis. J Invest Dermatol 129:2175–83
Hedrick MN, Lonsdorf AS, Shirakawa AK et al. (2009) CCR6 is required
for IL-23-induced psoriasis-like inflammation in mice. J Clin Invest
119:2317–29
Hwang J, Kita R, Kwon HS et al. (2011) Epidermal ablation of Dlx3 is linked
to IL-17-associated skin inflammation. Proc Natl Acad Sci USA 108:
11566–71
Jandus C, Bioley G, Rivals JP et al. (2008) Increased numbers of circulating
polyfunctional Th17 memory cells in patients with seronegative spondy-
larthritides. Arthritis Rheum 58:2307–17
Krueger GG, Langley RG, Leonardi C et al. (2007) A human interleukin-12/23
monoclonal antibody for the treatment of psoriasis. N Engl J Med
356:580–92
Leipe J, Grunke M, Dechant C et al. (2010) Role of Th17 cells in human
autoimmune arthritis. Arthritis Rheum 62:2876–85
Lloyd P, Ryan C, Menter A (2012) Psoriatic arthritis: an update. Arthritis
2012:176298
Lories RJ, de Vlam K (2012) Is psoriatic arthritis a result of abnormalities in
acquired or innate immunity? Curr Rheumatol Rep 14:375–82
Lubberts E (2010) Th17 cytokines and arthritis. Semin Immunopathol 32:43–53
McGonagle D, Ash Z, Dickie L et al. (2011) The early phase of psoriatic
arthritis. Ann Rheum Dis 70(Suppl 1):i71–6
McGonagle D, Lories RJ, Tan AL et al. (2007) The concept of a ‘‘synovio-
entheseal complex’’ and its implications for understanding joint inflam-
mation and damage in psoriatic arthritis and beyond. Arthritis Rheum
56:2482–91
McGonagle D, Tan AL, Benjamin M (2009) The nail as a musculoskeletal
appendage–implications for an improved understanding of the link
between psoriasis and arthritis. Dermatology 218:97–102
Murakami M, Hirano T (2012) The pathological and physiological roles of IL-6
amplifier activation. Int J Biol Sci 8:1267–80
Murakami M, Okuyama Y, Ogura H et al. (2011) Local microbleeding
facilitates IL-6- and IL-17-dependent arthritis in the absence of tissue
antigen recognition by activated T cells. J Exp Med 208:103–14
Nakajima K, Kanda T, Takaishi M et al. (2011) Distinct roles of IL-23 and IL-17
in the development of psoriasis-like lesions in a mouse model. J Immunol
186:4481–9
Nograles KE, Brasington RD, Bowcock AM (2009) New insights into the
pathogenesis and genetics of psoriatic arthritis. Nat Clin Pract Rheumatol
5:83–91
Nograles KE, Krueger JG (2011) Anti-cytokine therapies for psoriasis. Exp Cell
Res 317:1293–300
Ogura H, Murakami M, Okuyama Y et al. (2008) Interleukin-17 promotes
autoimmunity by triggering a positive-feedback loop via interleukin-6
induction. Immunity 29:628–36
Ohtani T, Ishihara K, Atsumi T et al. (2000) Dissection of signaling cascades
through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated
signals in immune responses. Immunity 12:95–105
Punzi L, Pianon M, Bertazzolo N et al. (1998) Clinical, laboratory and
immunogenetic aspects of post-traumatic psoriatic arthritis: a study of
25 patients. Clin Exp Rheumatol 16:277–81
Radtke MA, Reich K, Blome C et al. (2009) Prevalence and clinical features of
psoriatic arthritis and joint complaints in 2009 patients with psoriasis:
results of a German national survey. J Eur Acad Dermatol Venereol
23:683–91
Rahman P, Elder JT (2012) Genetics of psoriasis and psoriatic arthritis:
a report from the GRAPPA 2010 annual meeting. J Rheumatol 39:
431–3
Raychaudhuri SP, Raychaudhuri SK, Genovese MC (2012) IL-17 receptor
and its functional significance in psoriatic arthritis. Mol Cell Biochem
359:419–29
Ritchlin C, Haas-Smith SA, Hicks D et al. (1998) Patterns of cytokine
production in psoriatic synovium. J Rheumatol 25:1544–52
Sano S, Chan KS, Carbajal S et al. (2005) Stat3 links activated keratinocytes and
immunocytes required for development of psoriasis in a novel transgenic
mouse model. Nat Med 11:43–9
Sano S, Chan KS, DiGiovanni J (2008) Impact of Stat3 activation upon skin
biology: a dichotomy of its role between homeostasis and diseases.
J Dermatol Sci 50:1–14
Sawa S, Kamimura D, Jin GH et al. (2006) Autoimmune arthritis associated
with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-
dependent homeostatic proliferation of CD4þ T cells. J Exp Med
203:1459–70
Spuls PI, Hooft L (2012) Brodalumab and ixekizumab, anti-interleukin-17-
receptor antibodies for psoriasis: a critical appraisal. Br J Dermatol
167:710–3
Takata T, Taniguchi Y, Ohnishi T et al. (2011) 18)FDG PET/CT is a powerful
tool for detecting subclinical arthritis in patients with psoriatic arthritis
and/or psoriasis vulgaris. J Dermatol Sci 64:144–7
Tan AL, Benjamin M, Toumi H et al. (2007) The relationship between the
extensor tendon enthesis and the nail in distal interphalangeal joint
disease in psoriatic arthritis–a high-resolution MRI and histological study.
Rheumatology (Oxford) 46:253–6
Tan AL, Grainger AJ, Tanner SF et al. (2006) A high-resolution magnetic
resonance imaging study of distal interphalangeal joint arthropathy in
psoriatic arthritis and osteoarthritis: are they the same? Arthritis Rheum
54:1328–33
Tan ES, Chong WS, Tey HL (2012) Nail psoriasis: a review. Am J Clin Dermatol
13:375–88
Tsoi LC, Spain SL, Knight J et al. (2012) Identification of 15 new psoriasis
susceptibility loci highlights the role of innate immunity. Nat Genet
44:1341–8
Zaba LC, Cardinale I, Gilleaudeau P et al. (2007) Amelioration of epidermal
hyperplasia by TNF inhibition is associated with reduced Th17 responses.
J Exp Med 204:3183–94
Zenz R, Eferl R, Kenner L et al. (2005) Psoriasis-like skin disease and arthritis
caused by inducible epidermal deletion of Jun proteins. Nature 437:
369–75
M Yamamoto et al.
Psoriatic Skin Lesions Facilitate Arthritis
www.jidonline.org 453
